NEW YORK (GenomeWeb News) – BioReference Laboratories said today that it will acquire certain assets of Edge Biosystems, a reagents and sequencing services company.

As part of the agreement, BioReference's subsidiary GeneDx will acquire EdgeBio's genetic sequencing service business, Edge BioServ, which provides sequencing services in a CLIA certified laboratory. EdgeBio will retain its products business, a company official told GenomeWeb Daily News.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.